Vivimed Labs (NSE:VIVIMEDLAB) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 11, 2026)


NSE:VIVIMEDLAB Vivimed Labs Ltd NSE:VIVIMEDLAB
42 GF Score
Price ₹5.41
GF Value ₹2.55
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vivimed Labs 5-Year Yield-on-Cost %?

Vivimed Labs NSE:VIVIMEDLAB 42 5-Year Yield-on-Cost % is 0.00 as of Jul. 11, 2026. GuruFocus rates NSE:VIVIMEDLAB with a GF Score™ of 42/100 and a GF Value™ of ₹2.55 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 516 Drug Manufacturers companies, Vivimed Labs ranks worse than 193798.26% on this metric.

Vivimed Labs's yield on cost for the quarter that ended in Dec. 2025 was 0.00.


The historical rank and industry rank for Vivimed Labs's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Vivimed Labs's highest Yield on Cost was 2.85. The lowest was 0.00. And the median was 0.90.


NSE:VIVIMEDLAB's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.24
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Vivimed Labs  (NSE:VIVIMEDLAB) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Vivimed Labs 5-Year Yield-on-Cost % Related Terms


NSE:VIVIMEDLAB vs ZTS, UTHR: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vivimed Labs's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivimed Labs 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivimed Labs's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Vivimed Labs's 5-Year Yield-on-Cost % falls into.


NSE:VIVIMEDLAB
42GF Score
Vivimed Labs Ltd NSE:VIVIMEDLAB
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivimed Labs 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Vivimed Labs is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Vivimed Labs (NSE:VIVIMEDLAB) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vivimed Labs and its competitors. According to the industry distribution chart, Vivimed Labs ranks #999999 out of 516 companies in the Drug Manufacturers industry.
Is Vivimed Labs' 5-Year Yield-on-Cost % too high?
Vivimed Labs' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Vivimed Labs ranks #999999 out of 516 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vivimed Labs has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vivimed Labs' 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vivimed Labs ranks #999999 out of 516 companies for 5-Year Yield-on-Cost %. This places Vivimed Labs in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.24, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vivimed Labs and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vivimed Labs's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivimed Labs stock overvalued right now?
Based on GuruFocus' analysis, Vivimed Labs (NSE:VIVIMEDLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.55, compared to a current price of ₹5.41 — trading 112.2% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Vivimed Labs' overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Vivimed Labs (NSE:VIVIMEDLAB), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivimed Labs (NSE:VIVIMEDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vivimed Labs stock appears to be overvalued. The current stock price of ₹5.41 is trading 112.2% above its estimated GF Value™ of ₹2.55. GuruFocus considers Vivimed Labs to be Significantly Overvalued.

Key valuation signals for NSE:VIVIMEDLAB:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: ₹2.55 vs. price of ₹5.41 (112.2% above fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the NSE:VIVIMEDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vivimed Labs Business Description

Other Exchanges 532660:India
Address Green Lands, Beside The Plaza Hotel, D.No. 6-3-866/1/G1, 3rd & 4th Floor, GMR Towers, Begumpet, Hyderabad, TG, IND, 500016
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments: the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
42GF Score

Get the complete analysis for NSE:VIVIMEDLAB

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.41
Price
₹2.55
GF Value